14 Mar 2023 Oxurion provides update on recruitment for KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema and announces Board changes Member news
09 Mar 2023 Cancer Research UK signs multi-project collaboration with UCB to advance oncology antibody candidates Member news
06 Mar 2023 Mithra announces promising topline safety results from Donesta® Phase 3 Study in North America Member news
02 Mar 2023 CMT Research Foundation (USA) collaborates with Augustine Therapeutics on new therapy against Charcot-Marie-Tooth disease Member news
02 Mar 2023 Mithra announces compelling initial preclinical data in its research collaboration on novel tyrosine kinase inhibitors with BCI Pharma Member news
01 Mar 2023 Sequana Medical announces positive results from CHIHUAHUA, Phase 1 clinical trial of second-generation DSR product for congestive heart failure Member news
01 Mar 2023 New biostimulant seed treatment set to boost wheat yields with reduced fertilizer use Member news
22 Feb 2023 ONTOFORCE partners with Princess Máxima Center to facilitate more efficient pediatric oncology research with innovative data technology Member news
13 Feb 2023 Odimma partners with myNEO for the clinical development of its personalized DNA-based cancer immunotherapy Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
